INSM Insmed Incorporated
Healthcare$108.87+2.48%ClosedMarket Cap: $23.60B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
32.48
P/S
28.10
EV/EBITDA
-20.35
DCF Value
$-172.23
FCF Yield
-4.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
81.6%
Operating Margin
-137.7%
Net Margin
-144.4%
ROE
-130.1%
ROA
-57.0%
ROIC
-65.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $306.0M | 83.8% | $-200.3M | $-163.6M | $— | — |
| Q4 null | $263.8M | 83.2% | $-249.7M | $-328.5M | $— | — |
| FY null | $606.4M | 79.4% | $-1.18B | $-1.28B | $— | — |
| Q3 null | $142.3M | 79.4% | $-366.0M | $-370.0M | $— | — |
| Q2 null | $107.4M | 73.9% | $-312.9M | $-321.7M | $— | — |
| Q1 null | $92.8M | 77.1% | $-248.1M | $-256.6M | $— | — |
| Q4 null | $104.4M | 75.0% | $-230.4M | $-235.5M | $— | — |
| FY null | $363.7M | 76.4% | $-878.3M | $-913.8M | $— | — |
| Q3 null | $93.4M | 77.3% | $-213.4M | $-220.5M | $— | — |
| Q2 null | $90.3M | 76.8% | $-288.9M | $-300.6M | $— | — |
| Q1 null | $75.5M | 76.9% | $-145.5M | $-157.1M | $— | — |
| Q4 2023 | $83.7M | 78.0% | $-178.3M | $-186.1M | $-1.28 | — |